An observational study in Coronary Artery Disease, sponsored by Scitech Produtos Medicos Ltda. Completed at 2 sites in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-18.
Sponsored by Scitech Produtos Medicos Ltda · Observational
Prospective, multicenter, single arm registry to monitor post-market clinical outcomes of patients treated with Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer.
Prospective, multicenter, single arm registry to assess the safety and performance of Inspiron Sirolimus-Eluting Stent with Biodegradable Polymer for the treatment of "real world" patients.
Patients with lesions in native coronary arteries measuring between 2.5 and 4.0 mm in diameter and 34 mm length treated only with Inspiron Sirolimus-Eluting Stent.
Exclusion Criteria:
Inspiron Drug Eluting stent implantation
MACE (major cardiac events)
Major cardiac events (death, myocardial infarction, target vessel revascularization)
Time frame: 12 months
Acute success
Acute success measured by Angiography after stent implantation
Time frame: up to 24 hours
Stent Thrombosis
Stent Thrombosis rate
Time frame: 24 months
MACE
Major cardiac events (death, myocardial infarction, target vessel revascularization)
Time frame: 24 months
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scitech Produtos Medicos Ltda